Sumitomo Mitsui Financial Group’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-60,000
Closed -$420K 192
2022
Q3
$420K Sell
60,000
-55,000
-48% -$1.93M 0.02% 143
2022
Q2
$417K Sell
115,000
-30,300
-21% -$1.29M 0.01% 156
2022
Q1
$1.32M Sell
145,300
-641,700
-82% -$46.2M 0.04% 115
2021
Q4
$8.39M Buy
787,000
+188,900
+32% +$22.6M 0.24% 53
2021
Q3
$5.97M Buy
598,100
+160,000
+37% +$23.3M 0.14% 67
2021
Q2
$2.6M Buy
438,100
+197,000
+82% +$31.9M 0.06% 88
2021
Q1
$2.86M Buy
241,100
+236,100
+4,722% +$54.8M 0.07% 72
2020
Q4
$27K Buy
+5,000
New +$1.02M ﹤0.01% 140

Other funds holding TDOC

Sumitomo Mitsui Financial Group's TDOC Position: Q4 2024 in Review

Sumitomo Mitsui Financial Group sold out of Teladoc Health (TDOC) in Q4 2024, closing a stake of 4,970 shares — an estimated $42K sold.

Sumitomo Mitsui Financial Group first reported a position in TDOC in Q1 2021 and held it in 15 quarters. The position peaked at $37.7M in Q1 2022. 381 funds tracked by Wall St. Rank hold TDOC as of Q4 2024.

  • Sumitomo Mitsui Financial Group reported no remaining Teladoc Health position as of Q4 2024 after selling out during the quarter.
  • Sumitomo Mitsui Financial Group sold 4,970 Teladoc Health shares in Q4 2024, an estimated $42K.
  • Sumitomo Mitsui Financial Group first reported a position in Teladoc Health in Q1 2021 and held it in 15 quarters.
  • Sumitomo Mitsui Financial Group's Teladoc Health position peaked at $37.7M in Q1 2022.
  • 381 funds tracked by Wall St. Rank held Teladoc Health as of Q4 2024.

Based on Sumitomo Mitsui Financial Group's 13F filing for Q4 2024, filed 13 Feb 2025.